(risperidone) extended-release injectable suspension
The information contained in this learning resource contains a portion of the product information. For full details see the product information by each product owner. A full list can be found in the References tab.
No9
No9
For patients who have never taken risperidone, establish tolerability with oral risperidone prior to initiating PERSERIS.
Initiate PERSERIS at a dose of 90 mg or 120 mg once monthly by subcutaneous injection. Do not administer more than one dose (90 mg or 120 mg total) per month.
For patients switching from oral risperidone:
Yes9
Powder for reconstitution (white to off-white to yellow solid)
+
Delivery System (colorless to yellow solution)9
Tap the barrel of the powder syringe to dislodge any packed powder, as powder can become packed during shipping.9 Place liquid syringe on top of the powder syringe, twist to connect, and then pass the contents back and forth between the syringes (using the plungers) to mix.9This process must be done gently for 5 cycles, and then more vigorously for an additional 55 cycles.9When fully mixed, the product should be a cloudy suspension that is uniform in color (white to yellow-green).
If any clear areas remain in the mixture, continue to mix until there is uniform color distribution.9
On completion of the mixing cycles, transfer all contents into the liquid syringe, then while maintaining slight pressure on the powder syringe plunger, pull back the liquid syringe plunger and twist the syringes apart. Attach the safety needle and check for uniform color and that it is free from foreign particles.9
None stated in PI
29
Single-dose two-syringe mixing system kit (90 mg or 120 mg)9
Total mass of the reconstituted product delivers the following amounts of active drug:
90 mg or 120 mg Q1M9
Q1M9
0.6 mL (90 mg dose) - 0.8 mL (120 mg dose):9
5/89
189
SC only (abdomen or back of the upper arm)9
n/a
n/a
18-gauge, 5/8-inch safety needle9
Powder for reconstitution (white to off-white to yellow solid)
+
Delivery System (colorless to yellow solution)9
Single-dose two-syringe mixing system kit
1 syringe prefilled with risperidone powder
+
1 syringe prefilled with the liquid delivery system
+
1 safety needle for drug administration9
Yes9
Store dose kit in the refrigerator (36°F-46°F; 2°C-8°C).9
May be stored unopened in original packaging at room temperature (68°F-77°F; 20°C-25°C) for up to 30 days prior to administration. After removal from the refrigerator, use within 30 days or discard.9
Not stated in PI
Not stated in PI
Allow dose kit package to come to room temperature (20°C-25°C; 68°F-77°F) for at least 15 minutes prior to preparation.9
Tap the barrel of the powder syringe to dislodge any packed powder, as powder can become packed during shipping.9 Place liquid syringe on top of the powder syringe, twist to connect, and then pass the contents back and forth between the syringes (using the plungers) to mix.9This process must be done gently for 5 cycles, and then more vigorously for an additional 55 cycles.9When fully mixed, the product should be a cloudy suspension that is uniform in color (white to yellow-green).
If any clear areas remain in the mixture, continue to mix until there is uniform color distribution.9
On completion of the mixing cycles, transfer all contents into the liquid syringe, then while maintaining slight pressure on the powder syringe plunger, pull back the liquid syringe plunger and twist the syringes apart. Attach the safety needle and check for uniform color and that it is free from foreign particles.9
None stated in PI
By clicking the button below you agree to the following:
I am a US Health Care Professional.
I understand that S.C.O.P.E. is for educational purposes only and not to be used for the treatment or diagnosis of schizophrenia, nor is it a substitute for clinical judgment or guidelines.